Yuguang Du Selected Research

Oligosaccharides

1/2022	Chitosan Oligosaccharides Regulate the Occurrence and Development of Enteritis in a Human Gut-On-a-Chip.
1/2022	Low deacetylation degree chitosan oligosaccharide protects against IL-1β induced inflammation and enhances autophagy activity in human chondrocytes.
9/2020	Blood-Brain Barrier Permeable Chitosan Oligosaccharides Interfere with β-Amyloid Aggregation and Alleviate β-Amyloid Protein Mediated Neurotoxicity and Neuroinflammation in a Dose- and Degree of Polymerization-Dependent Manner.
7/2019	Inhibition of Liver Tumor Cell Metastasis by Partially Acetylated Chitosan Oligosaccharide on A Tumor-Vessel Microsystem.
1/2019	Synthesis and Evaluation of a Chitosan Oligosaccharide-Streptomycin Conjugate against Pseudomonas aeruginosa Biofilms.
12/2018	Insight into carrageenases: major review of sources, category, property, purification method, structure, and applications.
11/2018	Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
6/2018	Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice.
2/2018	Chitin Oligosaccharide Modulates Gut Microbiota and Attenuates High-Fat-Diet-Induced Metabolic Syndrome in Mice.
12/2017	Antrodia cinnamomea Oligosaccharides Suppress Lipopolysaccharide-Induced Inflammation through Promoting O-GlcNAcylation and Repressing p38/Akt Phosphorylation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuguang Du Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 08/2006
9	Inflammation (Inflammations) 01/2022 - 02/2014
4	Infections 01/2022 - 05/2018
3	Body Weight (Weight, Body) 06/2020 - 11/2018
3	Neoplasm Metastasis (Metastasis) 07/2019 - 02/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2017
2	Glucose Metabolism Disorders 01/2019 - 02/2018
2	Dysbiosis 01/2019 - 06/2018
2	Obesity 11/2018 - 01/2009
2	Dehydration (Water Stress) 04/2011 - 02/2011
2	Leukemia 10/2006 - 08/2006
1	Influenza in Birds (Avian Flu) 10/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Osteoarthritis 01/2022
1	Enteritis 01/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	COVID-19 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Neuroinflammatory Diseases 09/2020
1	Lung Neoplasms (Lung Cancer) 10/2019
1	Liver Neoplasms (Liver Cancer) 07/2019
1	Emaciation 02/2019
1	Polydipsia 02/2019
1	Hyperglycemia 02/2019
1	Hyperphagia (Overeating) 02/2019
1	Glucose Intolerance 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Thrombosis (Thrombus) 12/2018
1	Type 2 Diabetes Mellitus (MODY) 06/2018
1	Insulin Resistance 06/2018
1	Communicable Diseases (Infectious Diseases) 05/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2018
1	Gastritis 02/2018
1	Carcinogenesis 05/2017
1	Hyperlipidemias (Hyperlipidemia) 04/2017
1	Dyslipidemias (Dyslipidemia) 04/2017
1	Carcinoma (Carcinomatosis) 07/2013

Drug/Important Bio-Agent (IBA)

13	OligosaccharidesIBA 01/2022 - 01/2014
10	ChitosanIBA 01/2022 - 02/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2011
5	Polysaccharides (Glycans)IBA 01/2019 - 02/2011
3	Biological ProductsIBA 01/2022 - 08/2006
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2013
3	oligochitosanIBA 07/2019 - 10/2009
3	Messenger RNA (mRNA)IBA 02/2018 - 01/2014
2	AntioxidantsIBA 01/2022 - 01/2009
2	CytokinesIBA 10/2019 - 11/2018
2	Fluorouracil (Carac)FDA LinkGeneric 05/2019 - 07/2013
2	Pharmaceutical PreparationsIBA 05/2019 - 10/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 05/2018
2	CarrageenanIBA 12/2018 - 01/2014
2	Inulin FDA Link 05/2018 - 02/2011
2	ChitinIBA 02/2018 - 04/2017
2	Therapeutic UsesIBA 02/2018 - 08/2006
2	LipopolysaccharidesIBA 12/2017 - 02/2014
2	Epidermal Growth Factor (EGF)IBA 05/2017 - 02/2017
2	LipidsIBA 04/2017 - 01/2009
2	5-hydroxymethylfurfural (hydroxymethylfurfural)IBA 04/2011 - 02/2011
2	AcidsIBA 04/2011 - 02/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2006 - 08/2006
1	Hemagglutinins (Hemagglutinin)IBA 10/2022
1	Protective AgentsIBA 01/2022
1	Glucosamine (Dona)IBA 01/2021
1	AerosolsIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 09/2020
1	Amyloidogenic ProteinsIBA 09/2020
1	Immunoglobulin M (IgM)IBA 06/2020
1	Secretory Immunoglobulin A (SIgA)IBA 06/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Caspase 3 (Caspase-3)IBA 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	Dihydrotachysterol (AT 10)IBA 07/2019
1	Streptozocin (Streptozotocin)FDA Link 02/2019
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	EndotoxinsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	PPAR gammaIBA 11/2018
1	Blood Glucose (Blood Sugar)IBA 06/2018
1	OccludinIBA 06/2018
1	Inflammation MediatorsIBA 06/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2017
1	E-SelectinIBA 02/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	GoldIBA 07/2013
1	Cadherins (E-Cadherin)IBA 12/2012
1	TantalumIBA 04/2011
1	hydroxide ionIBA 04/2011
1	niobium pentoxideIBA 02/2011

Therapy/Procedure

5	Therapeutics 01/2022 - 02/2017
1	Immunomodulation 09/2019
1	Precision Medicine 05/2019
1	Lab-On-A-Chip Devices 05/2019
1	Drug Therapy (Chemotherapy) 07/2013